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Background: Alcohol-induced damages such as brain atrophy and fatty liver are closely related to a disturbed lipid
metabolism. In animal models, a linkage between chronic alcohol consumption and changes in fatty acid (FA)
composition in various organs and cells is well known and there is some indication that this phenomenon could
be linked to behavioural alterations associated with alcohol addiction such as craving. However, the influence of
ethanol on secretory FA has not been investigated so far. In this study, we therefore aimed at investigating whether
there is a significant change of serum FA composition in patients suffering from alcohol dependence. We
compared patients before and after treatment (detoxication) with control individuals who did not suffer from
addiction. The roles of age, the duration and intensity of alcohol use and lifestyles were considered.
Methods: Serum FA was measured in 73 male ethanol dependent patients before and after alcohol withdrawal in
an in-patient setting. Additionally, of this group, 45 patients were matched with 45 healthy male volunteers as
controls.
Results: We found significant differences in the FA composition before and after detoxication as well as between
patients and controls. After detoxication, the values changed towards the ones in healthy controls. The main
finding during acute alcohol use was an increased oleic acid concentration above the level of the linoleic acid
concentration.
Conclusions: An elevated oleic/linoleic acid ratio seems to be a state marker for acute alcohol use and may be a
relevant trait marker during detoxification and possibly the subsequent therapeutic measures. The results of this
pilot study need to be replicated in a larger study also including female patients. Further, the specificity of this
potential biomarker needs to be determined.Background
Recently, the effect of the dose-dependent balance be-
tween antioxidative properties of polyphenoles contained
in many alcoholic beverages and the pro-oxidative effects
of alcohol itself has been discussed controversially [1,2].
Pro-oxidative vascular injuries are seen after heightened
alcohol consumption [3]. Pathological alcohol consump-
tion also often leads to hepatic diseases (fatty liver, liver
cirrhosis) which in turn may cause a disturbed metabolism
of fatty acids (FA) and phospholipids [4].* Correspondence: johannes.thome@med.uni-rostock.de
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reproduction in any medium, provided the orThe influence of chronic alcohol use on the FA metabol-
ism is not yet fully understood. Changes of the FA com-
position in various organs were found in studies based on
animal models after chronic alcohol abuse [5-8]. Human
studies are rare, and their findings, often based on rela-
tively small sample sizes, remain inconclusive [9]. Possible
benefits of the supplementation with polyunsaturated FAs
were investigated in a group of abstinent patients [10,11]
and an increased microviscosity and fluidity were found in
erythrocyte membranes of patients after chronic alcohol
use [12]. The peroxidation of lipids in patients could indi-
cate an injury of membranes by oxidative stress [13]. An
alcohol-induced overproduction of nitric oxide, which re-
acts with superoxide radicals to synthesise peroxynitrite,
might also represent one of the many possible causes for
the membrane damage [14].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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between alcoholism and FAs which are precursors of en-
dogenous cannabinoids (FA amides). These may play a
crucial role in the development of drug or alcohol in-
duced addictive behaviour [15]. In this context, it has
been shown recently that the consumption of even a
moderate amount of red wine reduces the concentra-
tions of plasma endocannabinoids, anandamide and 2-
arachidonoylglycerol [16].
Chronic alcohol use also leads to the downregulation of
the cannabinoid 1 receptor function. The synthesis of the
endogenous cannabinoid 1 receptor agonists arachido-
nylethanolamide and 2-arachidonylglycerol is increased by
abstinence after chronic alcohol use, and it blocks the de-
letion of the cannabonoid 1 receptor resulting from exces-
sive alcohol drinking [17,18]. A previous post-mortem
study of the brains of patients suffering from alcoholism
revealed that the activity of the endogenous cannabinoid
system may be influenced by the type of alcoholism
according to the Cloninger classification: Anandamide,
dihomo-gamma-linolenoyl ethanolamide and docosa-
hexaenoyl ethanolamide levels were significantly lower
when compared to controls especially in Cloninger’s type
1 alcoholics [19,20].
Further, there are pilot studies looking into the possibility
of using FA ethylic esters in the hair of individuals in order
to detect possible alcohol dependence [21,22].
However, the influence of ethanol on secretory FA has
not been investigated so far. Thus, the aim of this study
was to investigate whether there is a significant changeTable 1 Demographic data of the patient and control groups
Alcoholic patients Contro
N = 45 N =
Age (x ± sd) 40.56 ± 13.82 40.67 ± 13
BMI (x ± sd) 23.93 ± 3.42 25.46 ± 4
Alcohol units per day (x ± sd) 17.27 ± 8.90 1.00
0
Years of alcohol abuse (x ± sd) 8.97 ± 6.84
Concentration of breath alcohol (‰) 0.94 ± 0.98
N without any breath alcohol (%) 32.40
Days of in-patient treatment (x ± sd) 10.82 ± 3.01




≤ 2 times a week 67.6 6
< 2 times a week 17.6 1of serum FA composition in patients suffering from al-
cohol dependence.
Methods
Patient and control samples
Study I: 45 alcohol-dependent patients were included in
this naturalistic study. They voluntarily attended an in-
patient detoxification program at the Department of
Psychiatry, University of Rostock. Diagnoses were made
by an experienced psychiatrist according to ICD-10 cri-
teria in a clinical routine situation (without the use of
standardised psychometric instruments such as structured
interviews). The patients were matched for age (± 1 year)
and gender (all were male) with healthy controls (for the
demographic data of the samples see Table 1).
Study II: 73 alcohol-dependent patients within the
same setting as described above were investigated at ad-
mission and on the day of discharge.
The study protocol was approved by the local ethics
committee and was conducted in accordance with the
Declaration of Helsinki. Written informed consent was
obtained from all participants.
Studies I and II: Blood samples were taken in the
morning after admission for investigating FA compos-
ition in serum in the patient group. Exclusion criteria for
the patients were: a history of other psychiatric disorders
than alcohol dependence, neurological illness and
current or unstable medical illnesses or disabilities. Indi-
viduals on any kind of ongoing vitamin substitution were
also excluded from the study. All patients were free ofStudy I Study II
ls Wilk’s
λ P η.2 Power
Alcoholic patients
45 N = 73
.80 0.95 0.133 0.051 0.322 46.41 ± 6.07
.01 0.92 0.092 0.083 0.391 24.62 ± 3.88






Related samples Wilcoxon Rank test
2.2 P = 0.002 90.4
2.2 (n for controls is only 1) 0.0
6.7 12.5
6.7 80.6
6.7 P = 1.00 6.9
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The healthy controls were free of medical or neuropsychi-
atric illnesses and were judged to be mentally healthy by
an experienced psychiatrist. The average alcohol con-
sumption (1 alcohol unit = 20 g alcohol/d), the duration
and the severity of the alcohol abuse according to clinical
impression were assessed. The liver enzymes Gamma-
glutamyltransferase (GGT), Alanine-Aminotransferase
(ALAT) and Aspartate-Aminotransferase (ASAT) were
additionally analysed in the patients.
There were no differences related to age, gender, body
mass index (BMI), the number of vegetarians, and the
frequency of fish in the diet between both sub-groups.
However, the alcoholic patients were significantly more
often smokers and reported to drink substantially more
units of alcohol per day than the controls (Table 1).Analysis of FAs
Total lipids were extracted from each 100 microliters
blood-serum by means of chloroform/methanol 1:1 (v:v),
dried under nitrogen. The FA extracts were then methyl-
ated using boron-trifluoride/methanol (14:86 vol:vol),
and then re-extracted with neat pentane. All solvents
were of HPLC grade purity. The concentration of a
range of FA with chain-length of 14–22 C-atoms was
measured by means of capillary gas-chromatography
(HP 5890; pillar: Carbowax HP 20 M, detector: FID,
oven temp. 180-250°C, rate 1°/min.). The following FAs
were quantified (in brackets the trivial names and abbre-
viations used in the text) 14:0 (myristic acid; MYR); 16:0
(palmitic acid; PA); 16:1 (palmitoleic acid; PAI); 18:0
(stearic acid; STE); 18:1n-9 (oleic acid; OL); 18:2 n-6
(linoleic acid; LA); 18:3n-6 (γ-linolenic acid; GLA);
18:3n-3 (α-linolenic acid; ALA); 20:3n-6 (dihomo-γ-lino-
lenic acid; DGLA); 20:3n-9 (mead acid; MEAD); 20:4n-6
(arachidonic acid; AA); 20:5n-3 (eicosapentaenoic acid;
EPA); 22:6n-3 (docosahexaenoic acid; DHA). The rela-
tive concentration of each of these 13 serum FA was
assigned as a percentage of the concentration [mg/l] of
each FA divided by the sum of all 13 FA in mg/l. FA
values were presented as percentage and absolute mea-
sures. FA standards of the Sigma Company were used
for the quantitative and qualitative calibration, margaric
acid (17:0) was used as internal standard. The coefficient
of variation of the analytical method (CVM) was for
each FA much lower than the coefficient of variation
from patient to patient (CVP). [CVM of 14:0, 16:0, 16:1,
18:0, 18:1 and 18:2 ≤0.15; CVM of 18:3n-3, 18:3n-6,
20:3n-6, 20:4, 20:3n-9, 20:5 and 22:6 ≤ 0.22; CVP ≥ 0.6].
Blood of the patients and comparison group was col-
lected between 9.00 and 10.00 a.m., after overnight
fasting (the subjects had a quasi-empty bowel, only a fat-
free light breakfast was permitted).Statistical methods
Variance analysis repeated measurement design was
used to test for differences between the matched sam-
ples with all 13 FA concentrations or relative concentra-
tions as dependent variables. Related samples Wilcoxon
Rank test was applied to test for differences in the distri-
bution of categorical variables between the samples or
between before and after detoxification. One way
ANOVA was calculated to analyse differences in FA con-
centrations between those patients with pathological
liver enzyme concentrations and those with normal
values. These associations were additionally tested by
Spearman Rank correlation. The following ratios be-
tween various FA concentrations were also considered in
the analysis: oleic acid concentration : linoleic concen-
tration (Q1); Σ of all N-3 FA concentrations : Σ of all
n-6 FA concentrations (Q2); and Σ of all MUFA concen-
trations : Σ of all poly-unsaturated FA (PUFA) concen-
trations (Q3). The significance level for all tests was set
at p < 0.05. Because of the explorative nature of our
study, we did not correct the level of significance for
multiple testing. However, several results were highly
significant (p < 0.001) and might remain significant even
after a conservative correction for multiple testing, e.g.
according to Bonferroni. Data were analysed using SPSS
version 18 (SPSS Inc., Chicago, IL, USA).
Results
Study I – Comparison between alcohol dependent
patients and healthy controls
The alcohol dependent patients reported an average his-
tory of alcohol abuse of about 9 years with a range from
1 to 31 years. About 32% of the patients presented
themselves for detoxication without any breath alcohol
(sober), while the other 68% exhibited an average breath
alcohol concentration of 0.139 ± 0.089%, ranging from
0.011 to 0.306%.
Differences in FA concentration between alcohol
dependent patients and healthy controls
The absolute concentration of the FA was significantly
higher in the patients compared to the healthy controls
for PA, PAI, STE, OL, GLA, and ALA with the highest dif-
ference being for PAI followed by OL, whereas it was
higher in the controls for DHA (see Table 2). Table 2 also
gives the case numbers (n) and the power of the statistical
tests (i.e. the probability that the null hypothesis will be
rejected if the null hypothesis is false (type-II error)).
The percentage of the various FAs in relation to the
sum of all 13 analysed FAs was significantly higher in
the patient group for PA, PAI, STE, and OL, whereas
the relative concentration of MYR, LA, DGLA, AA,
EPA, and DHA was higher in the healthy controls with
the biggest difference for DHA followed by PAI. The
Table 2 Differences between alcohol dependent patients and matched controls in FA concentration (mean ± sd in μg/ml)
and their relative portion by variance analysis repeated measurement (Study I)
Alcoholic patients Controls Wilk’s λ P η.2 Power
MYR 23.25 ± 16.36 23.83 ± 23.20 1.00 0.892 <0.001 0.052
% 1.98 ± 0.79 3.07 ± 1.62 0.71 <0.001 0.292 0.986
PA 398.62 ± 241.02 264.29 ± 183.52 0.81 0.002 0.193 0.888
% 33.85 ± 2.82 32.17 ± 4.39 0.90 0.030 0.102 0.591
PAI 78.36 ± 52.67 30.56 ± 24.65 0.58 <0.001 0.419 1.00
% 6.52 ± 2.43 3.91 ± 1.21 0.49 <0.001 0.513 1.00
STE 89.81 ± 63.43 54.15 ± 35.23 0.76 0.001 0.236 0.950
% 7.64 ± 1.31 6.98 ± 1.22 0.86 0.010 0.143 0.755
OL 262.76 ± 153.53 144.81 ± 93.97 0.66 <0.001 0.340 0.996
% 22.32 ± 3.13 18.78 ± 1.97 0.53 <0.001 0.468 1.00
LA 232.48 ± 136.56 184.25 ± 114.09 0.92 0.061 0.077 0.468
% 20.25 ± 3.80 24.28 ± 4.16 0.59 <0.001 0.411 1.00
GLA 5.25 ± 3.83 3.61 ± 2.51 0.88 0.018 0.121 0.674
% 0.43 ± 0.19 0.49 ± 0.22 0.96 0.194 0.038 0.252
ALA 8.66 ± 6.84 5.03 ± 3.18 0.82 0.003 0.184 0.869
% 0.72 ± 0.24 0.70 ± 0.31 1.00 0.760 0.002 0.060
Mead 2.82 ± 2.65 1.99 ± 2.01 0.93 0.083 0.067 0.411
% 0.23 ± 0.10 0.29 ± 0.32 0.97 0.220 0.034 0.230
DGLA 12.54 ± 10.05 11.21 ± 7.63 0.99 0.496 0.011 0.103
% 1.04 ± 0.35 1.50 ± 0.52 0.64 <0.001 0.357 0.998
AA 45.68 ± 23.36 42.52 ± 28.69 0.99 0.496 0.011 0.105
% 4.12 ± 1.35 5.54 ± 1.58 0.66 <0.001 0.339 0.996
EPA 7.28 ± 6.02 6.57 ± 6.24 0.99 0.517 0.010 0.098
% 0.59 ± 0.32 0.89 ± 0.47 0.79 0.002 0.206 0.910
DHA 6.03 ± 4.52 10.82 ± 9.94 0.80 0.002 0.205 0.910
% 0.54 ± 0.25 1.40 ± 0.68 0.39 <0.001 0.606 1.00
Sum of FAs 1173.53 ± 671.12 783.63 ± 494.08 0.79 0.001 0.209 0.915
OL/LA 1.16 ± 0.34 0.80 ± 0.17 0.45 <0.001 0.546 1.00
ΣN-3 : ΣN-6 0.07 ± 0.02 0.10 ± 0.04 0.76 0.001 0.236 0.950
Σ MUFA : Σ PUFA 1.12 ± 0.36 0.68 ± 0.15 0.40 <0.001 0.598 1.00
OL % : LA % 1.16 ± 0.34 0.80 ± 0.17 0.48 <0.001 0.523 1.00
ΣN-3% : ΣN-6% 0.07 ± 0.02 0.10 ± 0.04 0.78 0.001 0.219 0.929
Σ MUFA% : Σ PUFA% 1.11 ± 0.36 0.68 ± 0.15 0.42 <0.001 0.580 1.00
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MUFA/PUFA (Q3) in blood serum were significantly
higher in the patient than in the control group, both based
on the absolute and on the relative values. In the opposite,
the ratio n-3/n-6 FAs (Q2) was significantly lower in the
patient than in the control group.
Relationships between FA concentration and background
variables
Age, BMI, smoking habits as well as the amount of fish in
the diet were not significantly related to any absolute orrelative FA concentration in both groups. However, the
sum of all FAs in serum was significantly associated with
age (R = 0.60; p <0.001); and the ratio Q1 (absolute: R =
0.45; p = 0.002; relative: R = 0.044; p = 0.003) as well as the
ratio Q3 (absolute: R = 0.54; <0.001; relative: R = 0.055;
p = <0.001) were in controls significantly correlated with
the BMI for the absolute and relative concentrations. Age
was significantly related to the ratio Q2 (R = 0.34; p = 0.024)
in the patient group. There was no further significant asso-
ciation between the number of years of alcohol abuse and
any FA concentration in the alcohol dependent patients.
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FAs’ concentration in alcohol dependent patients
Pathological ASAT concentrations were found in 47.1% of
the patient group; 38.2% exhibited pathological ALAT
values and 68.1% had a pathologic GGT score. The relative
concentrations of PAI and OL were significantly higher in
those alcohol dependent patients with a pathologically in-
creased ASAT (F = 10.48; p = 0.003 and F = 8.60; p = 0.006,
respectively) or GGT value (F = 4.43; p = 0.043 and F =
13.68; p = 0.001, respectively) than in those with a normal
ASAT or GGT value. The absolute concentration of the
FAs LA and AA (F = 7.10; p = 0.012 and F = 4.78; p =
0.036, respectively) was significantly higher in those pa-
tients with normal ASAT values compared to those with
pathologically high values. Furthermore, the relative con-
centration for LA was higher in those patients with nor-
mal values in ASAT, ALAT, or GGT concentration (F =
13.65; p = 0.001, F = 5.44; p = 0.026 and F = 12.08; p =
0.001, respectively) compared to those with pathological
values; and the relative concentration of AA was higher in
patients with a normal ASAT value (F = 8.29; p = 0.007);
that of LA was higher in patients with a normal ALAT
value (F = 5.44; p = 0.026); and that of GLA was higher in
patients with a normal GGT value (F = 5.76; p = 0.026)
compared to those pathological concentrations of these
FAs. The sum of all FAs in serum did not differ between
those patients with pathologically high or normal liver
enzyme concentrations. However, alcohol dependent
patients with pathologically elevated liver enzyme con-
centrations showed significantly higher ratios Q1 and
Q3 than the patients with normal liver enzyme concen-
trations for the absolute as well as for relative FA con-
centrations (Table 3).
Those patients with elevated liver enzyme concentra-
tion additionally had higher concentrations of alcohol in
their breath at admission (ASAT: F = 19.13; p < 0.001,
ALAT: F = 6.63; p = 0.015; and GGT: F = 5.32; p = 0.028).
Furthermore, the concentration of alcohol was positively
correlated with the relative concentration of PAI, and
negatively with the relative concentration of the FAs LA,
GLA, DGLA, and AA.
The only absolute FA concentration which was signifi-
cantly correlated with liver enzyme concentrations wasTable 3 Differences in FA ratios between groups with
different liver enzyme concentration
ASAT ALAT GGT
F P F P F P
OL: LA 13.09 0.001 5.13 0.030 15.73 < 0.001
OL % : LA% 12.99 0.001 5.06 0.031 15.59 < 0.001
MUFA : PUFA 15.95 < 0.001 5.06 0.032 15.28 < 0.001
MUFA % : PUFA % 15.80 < 0.001 5.08 0.031 15.06 < 0.001that for PA (ASAT: R = 0.42; p = 0.014; ALAT: R = 0.38;
p = 0.025).
Substantial associations between all three determined
liver enzyme concentrations and relative FA concentra-
tions occurred for PAI, OL (positive), and LA (negative);
whereas GGT concentration was additionally negatively
related with the relative concentrations of GLA, DGLA,
and AA. The concentrations of ASAT and ALAT were
significantly correlated with the ratios of FAs Q1 %, Q2,
Q2 %, Q3, and Q3 %. The ratios Q1, Q3, and Q3 % were
additionally significantly associated with the GGT con-
centration, whereas the alcohol concentration was only
substantially related to Q3 and Q3 % (Table 4).
Study II – Comparison between alcohol dependent
patients before and after detoxification
Differences in FA concentration before and after detoxifi-
cation from alcohol The absolute concentrations of the
FAs were significantly higher before compared to after
detoxification for PA, PAI, STE, OL, GLA, ALA, AA,
and EPA with highest differences for ALA followed by
PA (see Table 5).
The percentage of PA, PAI, STE and OL in relation to
the sum of all 13 analysed FAs was significantly higher
before compared to after detoxification, whereas the
relative concentration of LA and DGLA was lower be-
fore detoxification. There was no significant difference
in the relative concentrations of GLA, ALA, DGLA, AA,
and EPA the absolute concentration of LA and in both
absolulate and relative concentrations of MEAD and
DHA before and after detoxification. All three ratios Q1,
Q2, Q3 based on the absolute and the relative concen-
trations as well as the total sum of FAs were significantly
higher before compared to after detoxification.
However, when controlling the one-way ANOVAs for
age, alcohol concentration, years of alcohol abuse, num-
ber of days of in-patient treatment, and number of aver-
age alcohol units per day (as co-variates), none of the
tested comparisons remained significant. Age was the
variable with the most substantial impact on these corre-
lations indicated by the “re-occurrence” of significant
differences in most FA concentrations when age was ex-
cluded from the list of co-variate variables.
Relationships between FA concentration and background
variables
The amount of fish in the diet, the years of alcohol abuse,
the average number of alcohol units drunken per day,
BMI, and age were not significantly related to any absolute
or relative FA concentration at both assessment time
points. Smokers had lower absolute MYR, GLA, DGLA,
and EPA concentrations before detoxification (F = 18.05;
p < 0.001; F = 5.41; p = 0.023; F = 11.20; p = 0.001; F = 6.57;
p = 0.012, respectively) and lower absolute PA, PAI, LA,
Table 4 Selected Spearman Rank correlations between relative FAs’ concentration and liver enzyme concentration
(R (p))
ASAT ALAT GGT Breath alcohol concentration
PAI % 0.61 (<0.001) 0.39 (0.021) 0.53 (0.001) 0.43 (0.012)
OL % 0.45 (0.008) 0.20 (0.089) 0.50 (0.003) 0.13 (0.477)
LA % −0.59 (<0.001) −0.43 (0.011) −0.47 (0.005) −0.36 (0.036)
GLA % −0.25 (0.148) −0.13 (0.470) −0.43 (0.011) −0.14 (0.425)
DGLA % −0.31 (0.077) −0.13 (0.448) −0.34 (0.050) −0.49 (0.004)
AA % −0.34 (0.050) −0.18 (0.305) −0.50 (0.002) −0.43 (0.012)
OL : LA 0.58 (<0.001) 0.39 (0.024) 0.52 (0.002) 0.32 (0.068)
OL : LA% 0.59 (<0.001) 0.39 (0.021) 0.52 (0.002) 0.31 (0.070)
Σ N-3 : Σ N-6 0.43 (0.011) 0.36 (0.038) 0.28 (0.115) 0.23 (0.182)
Σ N-3 : Σ N-6% 0.42 (0.014) 0.36 (0.036) 0.25 (0.151) 0.21 (0.234)
Σ MUFA : Σ PUFA 0.65 (<0.001) 0.42 (0.013) 0.61 (<0.001) 0.44 (0.009)
Σ MUFA : Σ PUFA % 0.64 (<0.001) 0.42 (0.013) 0.61 (<0.001) 0.44 (0.009)
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p = 0.036; F = 8.19; p = 0.006; F = 4.37; p = 0.040; F = 10.35;
p = 0.002, respectively). Furthermore, Q2 based on the
relative concentrations was lower in smokers before de-
toxification (F = 7.49; p = 0.008). The alcohol concentra-
tion at admission was significantly correlated with the
concentrations of MYR, PA, PAI, OL, GLA, and ALA
(F = 0.30; p = 0.017; F = 0.31; p = 0.008; F = 0.43; p <
0.001; F = 0.36; p = 0.002; F = 0.026; p = 0.028; F = 0.33;
p = 0.004, respectively) as was the relative concentration
of ALA (F = 0.27; p = 0.21).
Associations between liver enzyme and FA concentrations
Pathologically increased ASAT concentrations were found
in 58.9% of the alcohol dependent patients; 53.4% exhibited
increased ALAT concentrations and 78.1% had an in-
creased GGT score. The relative concentration of PA was
higher in those alcohol dependent patients with an ASAT
concentration within the normal range before (F = 18.79;
p < 0.001) and after detoxification (F = 5.71; p = 0.019)
compared to those with pathological ASAT concentration;
whereas the relative concentration of PAI was higher in pa-
tients with a pathological, i.e. increased ASAT concentra-
tion (before: F = 20.90; p < 0.001; after: F = 7.39; p = 0.006).
The absolute concentration of PAI (F = 4.17; p = 0.045) and
ALA (F = 4.23; p = 0.043) as well as the relative concentra-
tion of OL (F = 6.69; p = 0.012) and ALA (F = 4.39; p =
0.040) were higher before detoxification in those with an
increased ASAT concentration; but the relative concentra-
tion of MYR was higher in those with a normal ASAT
value (F = 7.22; p = 0.009) only before detoxification.
The relative PAI concentration was higher in patients
with increased ALAT or GGT concentrations at both as-
sessments (before: F = 8.13; p = 0.006; F = 4.83; p = 0.031,
respectively; after: F = 9.47; p = 0.003; F = 6.03; p = 0.016,
respectively); whereas the relative PA concentration washigher in patients with normal ALAT or GGT scores
only before detoxification (F = 10.43; p = 0.002; F 4.78;
p = 0.032, respectively).
The ratio between the two FA concentrations Q2 and
Q3 was significantly higher in patients with an in-
creased ASAT concentration before detoxification (ab-
solute: F = 10.60; p = 0.002; relative: F = 10.13; p = 0.002;
absolute: F = 5.48; p = 0.022; relative: F = 5.45; p = 0.022,
respectively), but not after detoxification. The ratio be-
tween the FA concentrations Q1 and Q3 was signifi-
cantly higher in patients with an increased ALAT
concentration only after detoxification (absolute: F =
4.67; p = 0.020; relative: F = 4.63; p = 0.035; absolute: F =
5.16; p = 0.026; relative: F = 5.07; p = 0.027, respectively).
Those with an increased GGT concentration did not dif-
fer from patients with a normal GGT value in any FA
based ratio.
Furthermore, the concentration of ASAT and GGT was
significantly correlated with age (R = 0.24; p = 0.042; R =
0.23; p = 0.048, respectively), and the ASAT concentration
was correlated with the alcohol concentration (R = 0.30;
p = 0.009).
Study I and Study II
The concentrations of all FAs (absolute and relative
values) as well as all three analysed FA ratios that signifi-
cantly differed between alcohol dependent patients and
controls (Study I) were found to be closer to the control
levels in the patients after detoxification (Study II) indi-
cating a tendency towards normalisation of the FA con-
centrations during the course of detoxification (lower
absolute and relative values for PA, PAI, STE, OL, Q1,
Q2, and Q3; only for absolute values for GLA, ALA,
AA, EPA, and the sum of all FAs; higher relative concen-
tration for LA and DGLA). However, when comparing
the FA concentrations of the controls from Study I with
Table 5 Differences before and after detoxification in FA concentration (mean ± sd in μg/ml) and their relative portion
by variance analysis, repeated measurement (Study II)
Alcoholic patients before detoxification Alcoholic patients after detoxification Wilk’s λ P η.2 Power
MYR 27.73 ± 26.52 21.98 ± 14.42 0.95 0.068 0.051 0.447
% 2.25 ± 0.95 2.28 ± 1.07 1.00 0.811 0.001 0.056
PA 428.37 ± 322.80 303.15 ± 150.71 0.84 <0.001 0.162 0.958
% 34.40 ± 2.69 33.10 ± 3.30 0.86 0.001 0.143 0.928
PAI 104.60 ± 160.70 42.45 ± 31.89 0.84 <0.001 0.160 0.955
% 7.33 ± 2.90 4.56 ± 1.50 0.39 <0.001 0.614 1.00
STE 93.60 ± 58.05 78.91 ± 42.03 0.94 0.038 0.059 0.552
% 7.58 ± 1.30 8.46 ± 1.48 0.78 <0.001 0.217 9.993
OL 299.79 ± 283.12 187.13 ± 84.89 0.84 <0.001 0.156 0.950
% 23.60 ± 3.32 20.95 ± 2.34 0.63 <0.001 0.373 1.00
LA 211.92 ± 114.13 213.27 ± 103.41 1.00 0.922 <0.001 0.051
% 18.02 ± 4.12 23.52 ± 3.67 0.42 <0.001 0.577 1.00
GLA 4.84 ± 2.75 3.83 ± 2.54 0.92 0.013 0.084 0.715
% 0.42 ± 0.15 0.43 ± 0.30 1.00 0.751 0.001 0.061
ALA 8.53 ± 6.99 5.41 ± 2.58 0.83 <0.001 0.166 0.962
% 0.69 ± 0.23 0.70 ± 0.75 1.00 0.850 0.001 0.054
Mead 2.96 ± 2.32 2.54 ± 1.75 0.97 0.160 0.027 0.289
% 0.24 ± 0.11 0.27 ± 0.14 0.96 0.095 0.038 0.387
DGLA 10.53 ± 5.32 11.34 ± 6.97 0.99 0.327 0.081 0.164
% 0.92 ± 0.29 1.22 ± 0.39 0.68 <0.001 0.325 1.00
AA 44.49 ± 25.36 36.62 ± 22.40 0.92 0.014 0.081 0.702
% 3.77 ± 1.31 4.01 ± 1.32 0.98 0.183 0.024 0.263
EPA 7.29 ± 6.24 4.94 ± 3.51 0.87 0.001 0.133 0.906
% 0.59 ± 0.30 0.59 ± 0.51 1.00 0.965 <0.001 0.050
DHA 5.55 ± 3.73 4.90 ± 3.95 0.98 0.185 0.024 0.262
% 0.47 ± 0.23 .51 ± 0.22 0.98 0.250 0.18 0.208
Sum of FAs 1255.36 ± 982.64 916.18 ± 435.15 0.87 0.002 0.126 0.889
OL : LA 1.44 ± 0.63 0.92 ± 0.22 0.58 <0.001 0.419 1.00
ΣN-3 : ΣN-6 0.08 ± 0.02 0.06 ± 0.02 .65 <0.001 0.346 1.00
Σ MUFA : Σ PUFA 1.40 ± 0.68 0.87 ± 0.22 0.58 <0.001 0.421 1.00
OL % : LA % 1.44 ± 0.63 0.92 ± 0.22 0.58 <0.001 0.419 1.00
ΣN-3 % : ΣN-6 % .08 ± 0.02 0.06 ± 0.03 0.87 0.002 0.129 0.895
Σ MUFA% : Σ PUFA% 1.40 ± 0.68 0.86 ± 0.22 0.57 <0.001 0.427 1.00
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(t-tests for independent samples), the patients still
showed higher absolute and relative concentrations for
PAI (absolute: t = 2.14; p = 0.035; relative: t = 2.44; p =
0.016), STE (absolute: t = 3.30; p = 0.001; relative: t = 5.62;
p < 0.001), and OL (absolute: t = 2.53; p = 0.013; relative:
t = 5.17; p < 0.001), and lower values for DHA (absolute:
t = 3.82; p < 0.001; relative: t = 10.48; p < 0.001). Further-
more, the relative concentrations were still higher in the
controls for MYR, DGLA, AA, and EPA (t = 2.88; p =
0.005; t = 3.32; p = 0.001; t = 5.68; p < 0.001; t = 3.15; p =0.002, respectively). The ratios Q1 and Q3 were still sig-
nificantly higher in the patients than in the controls (abso-
lute: t = 3.46; p = 0.001; t = 5.59; p < 0.001, respectively;
relative: t = 3.44; p = 0.001; t = 5.43; p < 0.001, respectively),
whereas the ratio Q2 was still higher in the controls (abso-
lute: t = 6.35; p < 0.001; relative: t = 4.88; p < 0.001).
Discussion
The PUFA composition of the cell membrane lipids is
most important for its fluidity and permeability. The
embedded FAs affect the membrane function dependent
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enriched diet reduces the microviscosity and increases the
unsaturation index of microsomal membranes in rats [23].
An unweighted PUFA composition might therefore con-
tribute to a dysfunctional metabolism observed in the cen-
tral nervous system of alcohol dependent patients [24].
Changes of the FA metabolism due to nutritional behav-
iour are reflected in serum concentrations much faster
than in membranes or adipose tissue [25]. Therefore (and
because of accessibility and convenience), we used serum
and not membranes as substrate to analyse FA concentra-
tions during the course of short-term alcohol detoxifica-
tion, assuming that the changes in serum FAs may have a
connection to their membrane composition.
Alcoholism often is related to poorer nutritional uptake of
FAs. Decreased nutrient densities of saturated, monounsatu-
rated, polyunsaturated, linoleic, and alpha-linolenic acids
have been associated with increasing alcohol consumption
in alcohol dependent men [26]. In our study, the habits of
fish consumption and vegetarism did not substantially differ
between patients and controls; but, the alcohol dependent
individuals did significantly more often use tobacco.
MUFAs
The most robust characteristic of serum FA composition
of untreated alcoholic patients is the increase of oleic acid
at the cost of linoleic acid. Normally, in the whole serum
the predominant FA of the C18 group is linoleic acid (un-
published data). An elevated level mono-unsaturated FAs
(MUFA) in plasma was observed in rats after chronic etha-
nol feeding [27]. Furthermore, the percentage of MUFA
was higher in white and brown adipose tissues of alcohol-
treated rats, compared to control animals without alcohol
exposure [28]. The presence of ethyl oleate (besides other
FA ethylic esters) increased by more than 10 fold in mouse
liver extracts after alcohol administration [29]. In individ-
uals with so-called intermittent explosive disorder, who all
had alcohol abuse problems, the concentration of Linoleic
acid, the precursor of the n-6 FAs, was below normal,
while oleic acid was elevated in plasma [30].
PUFAs
Maturu et al. [31] examined the relation of FA compos-
ition of erythrocyte membrane phospholipids with the
plasma lipid profile and other plasma metabolites in pa-
tients suffering from chronic alcoholism in comparison
with healthy controls. They found changes in the erythro-
cyte membrane of patients, namely higher palmitic acid
(saturated) and lower special n-3 FAs. Alcohol-induced
FA alterations in plasma and erythrocyte membranes were
assumed to be an adaptive response in order to counteract
the deleterious effects of alcohol.
DHA is particularly vulnerable to oxidative damage in
ethanol withdrawal [32].No significant differences were found between a group of
80 alcohol dependent patients with oral supplementation
of 2 g PUFAS for 3 months and a placebo group regarding
the reduction of the amount of alcohol ingestion; further
measured parameters in this placebo/controlled, double
blind, randomized study were patients’ craving and alcohol
dependence severity scores [24]. The capsules contained n-
3 and n-6 PUFAs in a ratio of approximately 3.5 : 1.
Our results confirm those of Rosnowska et al. [9] who
examined 25 alcohol-dependent patients before and after
clinical detoxification; the authors found an increased
oleic acid level accompanied by a decrease in linoleic
acid and in total FAs before detoxication, probably due
to the stimulation with hydrogen excess formed during
alcohol fermentation. Therefore, it might be speculated
that the ratio of oleic (MUFA)/ to linoleic acid (n-6
PUFA) discriminates better than n-3/n-6 PUFAs be-
tween the metabolism during acute alcohol intoxication
and normalized metabolism.
Mechanism
The mechanism by which chronic ethanol consumption
reduces the concentrations of PUFAs was examined by
Pawlosky et al. [33]: In livers of alcohol dependent men,
more radioactive labelled linolenic and 22:5 n-3 acid
were utilized for the synthesis of EPA and DHA, than
was predicted from plasma kinetics. This ability to
utilize linolenic acid for the synthesis of longer chained
PUFA was greater in alcohol dependent individuals than
in controls.
From animal experiments it is known, that heavy alco-
hol consumption increases the synthesis of FAs in the
liver and mobilizes the peripheral triglycerides from the
adipose tissue into the liver [34]. In rats, the unsatur-
ation of fatty acyl chains after alcohol feeding increased
in the liver, whereas it decreased in plasma [35].
Oleic acid constitutes the main FA component in the
human serum lipid fraction of triglycerides (unpublished
data). After the breakdown of triglyceride molecules in
the liver, oleic acid may be the source for the de novo-
synthesis of FAs. Similarly, oleic acid is the main FA
component in the serum free FAs (unpublished data).
Warensjö et al. [36] suggested that serum FA compos-
ition reflects the endogenous FA synthesis catalysed by
Delta-desaturases despite dietary fat intake. They de-
scribed an effect, similar to the alcohol-induced shifts in
oleic/ linoleic acid in our study, in the cholesteryl esters
of men with metabolic syndrome and suggested that
serum “FA composition predicts the long-term develop-
ment of the metabolic syndrome, and Delta-5
Desaturase activity may be particularly important in this
process. The possibility that altered FA composition,
partly secondary to genetic or hormonal factors, should
also be considered” [36].
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be the Stearoyl-Coenzyme A desaturase-1. The delta-9
FA desaturase Stearoyl-Coenzyme A desaturase-1 con-
verts saturated FAs into monounsaturated fatty acids
(MUFA) and this activity is elevated by dietary carbohy-
drate [37].
Changes in the distribution of saturated and unsaturated
FAs in the plasma phospholipid FA composition could in-
dicate a disturbance of FA metabolism [27].
Heavy ethanol use blocks FA oxidation through inhibi-
tions of peroxisome proliferator-activated receptor-α and
of AMP-activated protein kinase. Under certain condi-
tions, the de novo synthesis of FA in the liver can be in-
creased by ethanol feeding [34]. Additionally, acid
sphingomyelinase activity in plasma was found to be (re-
versibly) increased in patients with alcohol-dependence
and to correlate with lipoproteins [38]. In sphingomyelins,
oleic acid is bound in high concentrations.
Conclusion
Serum FA composition is influenced by alcohol abuse. It is
mainly characterised by a shift from linoleic to oleic acid as
the quantitatively predominant C 18 acid. After detoxifica-
tion, a normalization towards lower OL and higher LA acid
takes place. Possibly, the higher OL production serves as a
shelter mechanism against the damage of free radicals by
alcohol ingestion, since OL prevents among others TNF-α
induced oxidative stress mediated cardiomyocyte cell dam-
age [39]. Dietary intake of polyunsaturated fats increases
the probability of liver injuries in response to ethanol feed-
ing; however, increased levels of oleic acid and lower levels
of linoleic acid may lead to attenuated liver injuries after
toxine exposure [40]. OL and moderate wine consumption
are components of a so-called Mediterranean diet which
by some is believed to be protective against cancer and car-
diovascular diseases [41]. We assume that OL contributes
to alleviate the adverse reactions of alcohol consumption.
OL accumulation in serum seems to be a special effect of
alcohol: in the liver of mice with a non-alcoholic fatty liver
disease, a low concentration of OL was found [42].
In summary, our study provides insight in FA pattern
changes during long-term and heavy alcohol misuse
compared to healthy controls. Contrary to our expect-
ation, the most striking changes were not only decreased
concentrations of essential PUFAs in the patient group
before detoxification, but also increased MUFA concen-
trations (OL, PAI), thus these represent possible trait
markers. The influence of pre-existing liver damages and
different “lifestyle” factors must also be taken into con-
sideration. Further studies are needed in order to cor-
roborate our findings; liver enzymes should also be
measured in controls and additionally female individuals
should be examined as well in order to uncover possible
gender differences.Abbreviations
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